Kalos Management, Inc. Neoleukin Therapeutics, Inc. Transaction History

Kalos Management, Inc.

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$9.95 - $17.05 $144,772 - $248,077
-14,550 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$2.65 - $12.72 $927 - $4,452
-350 Reduced 2.35%
14,550 $177,000
Q3 2019

Nov 14, 2019
BUY
$2.33 - $3.76 $34,717 - $56,024
14,900 New
14,900 $42,000

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Kalos Management, Inc. Portfolio

Follow Kalos Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kalos Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email